A meta-analysis of efficacy and safety of aripiprazole in adult and pediatric bipolar disorder in randomized controlled trials and observational studies
详细信息 查看全文
- 作者：Martina Meduria ; 1 ; Giorgia Gregoracib ; 1 ; Valentina Baglivoa ; Matteo Balestrieria ; Miriam Isolab ; Paolo Brambillac ; d ; paolo.brambilla1@unimi.it" class="auth_mail" title="E-mail the corresponding author
- 关键词：FDA ; Food and Drug Administration ; EMA ; European Medicines Agency ; 5HT1A-5HT2A ; 5- hydroxytryptamine receptors ; D2 ; Dopamine Receptor D2
- 刊名：Journal of Affective Disorders
- 出版年：2016
- 出版时间：February 2016
- 年：2016
- 卷：191
- 期：Complete
- 页码：187-208
- 全文大小：1611 K
文摘
- item" id="list_li0595">
- •
We examine ARP efficacy and safety in adult and pediatric bipolar population.
- •
Both observational and RCTs were included.
- •
Acute (3-weeks) and stabilization (12-weeks) treatment phases are considered.